NeuroOne Medical Technologies Corporation
NMTCNASDAQHealthcare● Active
$3.46
+$0.02(+0.58%)
Market Cap$29824771
P/E Ratio—
52W High$6.96
52W Low$3.276
NeuroOne Medical Technologies Corporation (NMTC) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · NMTC · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-09 | 2024-09 | 2023-09 | 2022-09 | 2021-09 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $12.10M | $3.45M | $1.95M | $0.17M | $0.18M |
| Cost of Revenue | $3.96M | $2.37M | $1.50M | $0.24M | $0.28M |
| Gross Profit | $8.14M | $1.08M | $0.46M | ($0.07M) | ($0.10M) |
| Gross Margin %(computed) | 67.30% | 31.27% | 23.38% | -41.36% | -54.87% |
| Operating Expenses | |||||
| R&D Expenses | $4.98M | $5.07M | $6.94M | $4.93M | $3.93M |
| G&A Expenses | $0.00M | $7.79M | $6.75M | $6.71M | $5.92M |
| Total Operating Expenses | $12.37M | $12.97M | $12.41M | $9.96M | $10.12M |
| Operating Income | ($4.23M) | ($11.89M) | ($11.96M) | ($10.03M) | ($10.22M) |
| Operating Margin %(computed) | -34.94% | -344.26% | -612.32% | — | — |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.33M | $0.23M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($3.61M) | ($12.32M) | ($11.86M) | ($10.00M) | ($9.95M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($3.61M) | ($12.32M) | ($11.86M) | ($10.00M) | ($9.95M) |
| Net Margin %(computed) | -29.80% | -356.74% | -607.42% | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.54 | $-2.76 | $-3.90 | $-3.78 | $-5.58 |
| Wtd Avg Shares | 6.69M | 4.46M | 3.02M | 2.67M | 1.78M |
| EBITDA | ($3.01M) | ($11.84M) | ($11.76M) | ($9.91M) | ($9.80M) |
| EBITDA Margin %(computed) | -24.88% | -342.96% | -602.12% | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more NeuroOne Medical Technologies Corporation data
About NeuroOne Medical Technologies Corporation (NMTC) Income Statement
NeuroOne Medical Technologies Corporation (NMTC) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, NMTC reported revenue of $0.01B, gross profit of $0.01B (gross margin 67.30%), and net income of ($0.00B) — a net profit margin of -29.80%.
Frequently asked questions
NMTC · 4 questionsNeuroOne Medical Technologies Corporation (NMTC) reported revenue of $0.01B for 2025, up 250.4% year-over-year.
NMTC revenueNMTC salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09